An in vitro model of antibody-enhanced killing of the intracellular parasite leishmania amazonensis

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Gibson Corley, Katherine N ^b   Bockenstedt, Marie M ^a   Li, Huijuan ^a   Boggiatto, Paola M ^a   Phanse, Yashdeep ^a   Petersen, Christine A ^c   Bellaire, Bryan H ^a   Jones, Douglas E ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; GAMMA INTERFERON; IMMUNOGLOBULIN G2A; PARASITE ANTIGEN; PHOSPHATIDYLINOSITOL 3 KINASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; ANTIGEN ANTIBODY COMPLEX; IMMUNOGLOBULIN G; PROTOZOON ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CONTROLLED STUDY; CROSS PROTECTION; FEMALE; HOST RESISTANCE; IMMUNOCYTOTOXICITY; IN VITRO STUDY; INTRACELLULAR KILLING; LEISHMANIA; LEISHMANIASIS; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PARASITE CLEARANCE; SIGNAL TRANSDUCTION; ANIMAL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; DISEASE MODEL; IMMUNOLOGY; KNOCKOUT MOUSE; LEISHMANIA MEXICANA; MACROPHAGE; METABOLISM; PARASITOLOGY; SKIN LEISHMANIASIS;

LEISHMANIA AMAZONENSIS;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGEN-ANTIBODY COMPLEX; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOGLOBULIN G; IN VITRO TECHNIQUES; LEISHMANIA MEXICANA; LEISHMANIASIS, CUTANEOUS; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, KNOCKOUT; NADPH OXIDASE; PHOSPHATIDYLINOSITOL 3-KINASES; RECEPTORS, IGG; SIGNAL TRANSDUCTION; SUPEROXIDES;

EID: 84907000341     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106426     Document Type: Article

References (58)

1. Afonso LC, Scott P (1993) Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect Immun 61: 2952-2959.
2. Ji J, Sun J, Soong L (2003) Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis. Infect Immun 71: 4278-4288.
3. Lemos de Souza V, Ascencao Souza J, Correia Silva TM, Sampaio Tavares Veras P, Rodrigues de-Freitas LA (2000) Different Leishmania species determine distinct profiles of immune and histopathological responses in CBA mice. Microbes Infect 2: 1807-1815.
4. Anderson CF, Mendez S, Sacks DL (2005) Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice. J Immunol 174: 2934-2941.
5. Vanloubbeeck Y, Jones DE (2004) Protection of C3Heb/FeJ mice against Leishmania amazonensis challenge after previous Leishmania major infection. Am J Trop Med Hyg 71: 407-411.
6. Porrozzi R, Teva A, Amaral VF, Santos da Costa MV, Grimaldi G Jr (2004) Cross-immunity experiments between different species or strains of Leishmania in rhesus macaques (Macaca mulatta). Am J Trop Med Hyg 71: 297-305.
7. Veras P, Brodskyn C, Balestieri F, Freitas L, Ramos A, et al. (1999) A dhfr-ts- Leishmania major knockout mutant cross-protects against Leishmania amazonensis. Mem Inst Oswaldo Cruz 94: 491-496.
8. Gonzalez-Lombana CZ, Santiago HC, Macedo JP, Seixas VA, Russo RC, et al. (2008) Early infection with Leishmania major restrains pathogenic response to Leishmania amazonensis and parasite growth. Acta tropica 106: 27-38.
9. Courret N, Lang T, Milon G, Antoine J-C (2003) Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice. Int J Parasitol 33: 1373-1383.
10. Veras PS, Welby-Borges M, de Santana CD, Nihei J, Cardillo F, et al. (2006) Leishmania amazonensis: participation of regulatory T and B cells in the in vitro priming (PIV) of CBA/J spleen cells susceptible response. Exp Parasitol 113: 201-205.
11. Ji J, Sun J, Qi H, Soong L (2002) Analysis of T helper cell responses during infection with Leishmania amazonensis. Am J Trop Med Hyg 66: 338-345.
12. Ramer AE, Vanloubbeeck YF, Jones DE (2006) Antigen-responsive CD4+ T cells from C3H mice chronically infected with Leishmania amazonensis are impaired in the transition to an effector phenotype. Infect Immun 74: 1547- 1554.
13. Qi H, Popov V, Soong L (2001) Leishmania amazonensis-dendritic cell interactions in vitro and the priming of parasite-specific CD4(+) T cells in vivo. J Immunol 167: 4534-4542.
14. Boggiatto PM, Jie F, Ghosh M, Gibson-Corley KN, Ramer-Tait AE, et al. (2009) Altered dendritic cell phenotype in response to Leishmania amazonensis amastigote infection is mediated by MAP kinase, ERK. Am J Pathol 174: 1818- 1826.
15. Vanloubbeeck YF, Ramer AE, Jie F, Jones DE (2004) CD4+ Th1 cells induced by dendritic cell-based immunotherapy in mice chronically infected with Leishmania amazonensis do not promote healing. Infect Immun 72: 4455-4463.
16. Jones DE, Ackermann MR, Wille U, Hunter CA, Scott P (2002) Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin- 10-deficient mice does not lead to resolution of infection. Infect Immun 70: 2151-2158.
17. Qi H, Ji J, Wanasen N, Soong L (2004) Enhanced Replication of Leishmania amazonensis Amastigotes in Gamma Interferon-Stimulated Murine Macrophages: Implications for the Pathogenesis of Cutaneous Leishmaniasis. Infect Immun 72: 988-995.
18. Gomes I (2003) Differential properties of CBA/J mononuclear phagocytes recovered from an inflammatory site and probed with two different species of Leishmania. Microbes Infect 5: 251-260.
19. Mukbel RM, Patten C Jr, Gibson K, Ghosh M, Petersen C, et al. (2007) Macrophage killing of Leishmania amazonensis amastigotes requires both nitric oxide and superoxide. Am J Trop Med Hyg 76: 669-675.
20. Stenger S, Donhauser N, Thuring H, Rollinghoff M, Bogdan C (1996) Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J Exp Med 183: 1501-1514.
21. Sacks D, Noben-Trauth N (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2: 845-858.
22. Suh CI, Stull ND, Li XJ, Tian W, Price MO, et al. (2006) The phosphoinositidebinding protein p40phox activates the NADPH oxidase during FcgammaIIA receptor-induced phagocytosis. J Exp Med 203: 1915-1925.
23. Tian W, Li XJ, Stull ND, Ming W, Suh CI, et al. (2008) Fc gamma R-stimulated activation of the NADPH oxidase: phosphoinositide-binding protein p40phox regulates NADPH oxidase activity after enzyme assembly on the phagosome. Blood 112: 3867-3877.
24. Almeida TF, Palma LC, Mendez LC, Noronha-Dutra AA, Veras PS (2012) Leishmania amazonensis fails to induce the release of reactive oxygen intermediates by CBA macrophages. Parasite Immunol 34: 492-498.
25. Pham NK, Mouriz J, Kima PE (2005) Leishmania pifanoi amastigotes avoid macrophage production of superoxide by inducing heme degradation. Infect Immun 73: 8322-8333.
26. Lodge R, Diallo TO, Descoteaux A (2006) Leishmania donovani lipophosphoglycan blocks NADPH oxidase assembly at the phagosome membrane. Cell Microbiol 8: 1922-1931.
27. Pfefferkorn LC, Fanger MW (1989) Cross-linking of the high affinity Fc receptor for human immunoglobulin G1 triggers transient activation of NADPH oxidase activity. Continuous oxidase activation requires continuous de novo receptor cross-linking. J Biol Chem 264: 14112-14120.
28. Huang J, Canadien V, Lam GY, Steinberg BE, Dinauer MC, et al. (2009) Activation of antibacterial autophagy by NADPH oxidases. Proc Natl Acad Sci U S A 106: 6226-6231.
29. Bonetto S, Spadola L, Buchanan AG, Jermutus L, Lund J (2009) Identification of cyclic peptides able to mimic the functional epitope of IgG1-Fc for human Fc gammaRI. FASEB J 23: 575-585.
30. Kennedy AD, DeLeo FR (2008) PI3K and NADPH oxidase: A class act. Blood 112: 4788-4789.
31. Mukbel R, Petersen CA, Jones DE (2006) Soluble factors from Leishmania major-specific CD4+ T cells and B cells limit L. amazonensis amastigote survival within infected macrophages. Microb Infect 8: 2547-2555.
32. Gibson-Corley KN, Boggiatto PM, Mukbel RM, Petersen CA, Jones DE (2010) A deficiency in the B cell response of C57BL/6 mice correlates with loss of macrophage-mediated killing of Leishmania amazonensis. Int J Parasitol 40: 157-161.
33. Nimmerjahn F, Ravetch JV (2008) Analyzing antibody-Fc-receptor interactions. Methods Mol Biol 415: 151-162.
34. Phanse Y, Ramer-Tait AE, Friend SL, Carrillo-Conde B, Lueth P, et al. (2012) Analyzing cellular internalization of nanoparticles and bacteria by multi-spectral imaging flow cytometry. J Vis Exp: e3884.
35. Yuan H, Pupo MT, Blois J, Smith A, Weissleder R, et al. (2009) A stabilized demethoxyviridin derivative inhibits PI3 kinase. Bioorg Med Chem Lett 19: 4223-4227.
36. Miles SA, Conrad SM, Alves RG, Jeronimo SM, Mosser DM (2005) A role for IgG immune complexes during infection with the intracellular pathogen Leishmania. J Exp Med 201: 747-754.
37. Buxbaum LU (2008) A detrimental role for IgG and FcgammaR in Leishmania mexicana infection. Immunol Res 42: 197-209.
38. Wanasen N, Xin L, Soong L (2008) Pathogenic role of B cells and antibodies in murine Leishmania amazonensis infection. Int J Parasitol 38: 417-429.
39. Saha S, Mondal S, Banerjee A, Ghose J, Bhowmick S, et al. (2006) Immune responses in kala-azar. Indian J Med Res 123: 245-266.
40. ElShafie AI, Elghazali G, Ronnelid J, Venge P (2006) Cystatin C as a marker of immune complex-associated renal impairment in a Sudanese population with visceral leishmaniasis. Am J Trop Med Hyg 75: 864-868.
41. Kharazmi A, Rezai HR, Fani M, Behforouz NC (1982) Evidence for the presence of circulating immune complexes in serum and C3b and C3d on red cells of kala-azar patients. Trans R Soc Trop Med Hyg 76: 793-796.
42. Mary C, Ange G, Dunan S, Lamouroux D, Quilici M (1993) Characterization of a circulating antigen involved in immune complexes in visceral leishmaniasis patients. Am J Trop Med Hyg 49: 492-501.
43. Solano-Gallego L, Koutinas A, Miro G, Cardoso L, Pennisi MG, et al. (2009) Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis. Vet Parasitol 165: 1-18.
44. Woelbing F, Kostka SL, Moelle K, Belkaid Y, Sunderkoetter C, et al. (2006) Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity. J Exp Med 203: 177-188.
45. Rodriguez-Pinto D, Saravia NG, McMahon-Pratt D (2014) CD4 T cell activation by B cells in human Leishmania (Viannia) infection. BMC Infect Dis 14: 108.
46. Gibson-Corley K, Boggiatto PM, Bockenstedt MM, Petersen C, Waldschmidt TJ, et al. (2012) Promotion of a Functional B cell Germinal Center Response after Leishmania spp. Co-infection is Associated with Lesion Resolution. Am J Pathol 180: 2009-2017.
47. Kawai T, Akira S (2011) Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34: 637-650.
48. Nish S, Medzhitov R (2011) Host defense pathways: role of redundancy and compensation in infectious disease phenotypes. Immunity 34: 629-636.
49. Gallo P, Goncalves R, Mosser DM (2010) The influence of IgG density and macrophage Fc (gamma) receptor cross-linking on phagocytosis and IL-10 production. Immunol Lett 133: 70-77.
50. Jonsson F, Mancardi DA, Albanesi M, Bruhns P (2013) Neutrophils in local and systemic antibody-dependent inflammatory and anaphylactic reactions. J Leukoc Biol 94: 643-56.
51. Mancardi DA, Albanesi M, Jonsson F, Iannascoli B, Van Rooijen N, et al. (2013) The high-affinity human IgG receptor FcgammaRI (CD64) promotes IgGmediated inflammation, anaphylaxis, and antitumor immunotherapy. Blood 121: 1563-1573.
52. Pfefferkorn LC, Guyre PM, Fanger MW (1990) Functional comparison of the inductions of NADPH oxidase activity and Fc gamma RI in IFN gamma-treated U937 cells. Mol Immunol 27: 263-272.
53. Elshafie AI, Ahlin E, Mathsson L, ElGhazali G, Ronnelid J (2007) Circulating immune complexes (IC) and IC-induced levels of GM-CSF are increased in sudanese patients with acute visceral Leishmania donovani infection undergoing sodium stibogluconate treatment: implications for disease pathogenesis. J Immunol 178: 5383-5389.
54. Ambarus CA, Santegoets KC, van Bon L, Wenink MH, Tak PP, et al. (2012) Soluble immune complexes shift the TLR-induced cytokine production of distinct polarized human macrophage subsets towards IL-10. PloS One 7: e35994.
55. Tripp CS, Beckerman KP, Unanue ER (1995) Immune complexes inhibit antimicrobial responses through interleukin-10 production. Effects in severe combined immunodeficient mice during Listeria infection. J Clin Invest 95: 1628-1634.
56. Casadevall A, Pirofski LA (2012) A new synthesis for antibody-mediated immunity. Nat Immunol 13: 21-28.
57. Vouldoukis I, Riveros-Moreno V, Dugas B, Ouaaz F, Becherel P, et al. (1995) The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen. Proc Natl Acad Sci U S A 92: 7804-7808.
58. Vouldoukis I, Mazier D, Moynet D, Thiolat D, Malvy D, et al. (2011) IgE mediates killing of intracellular Toxoplasma gondii by human macrophages through CD23-dependent, interleukin-10 sensitive pathway. PloS One 6: e18289.